Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer’s disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer’s disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer’s disease.

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Squassina A.;Pisanu C.;
2021-01-01

Abstract

Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer’s disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer’s disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer’s disease.
2021
Age of Onset
Aged
Aged, 80 and over
Alzheimer Disease
Amyloid beta-Protein Precursor
Apolipoproteins E
Case-Control Studies
Cohort Studies
Datasets as Topic
Female
Follow-Up Studies
Genetic Predisposition to Disease
Genome-Wide Association Study
Heterozygote
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide
Risk Assessment
Risk Factors
Multifactorial Inheritance
File in questo prodotto:
File Dimensione Formato  
de rojas et al., 2021.pdf

accesso aperto

Tipologia: versione editoriale
Dimensione 4.4 MB
Formato Adobe PDF
4.4 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/324455
Citazioni
  • ???jsp.display-item.citation.pmc??? 75
  • Scopus 106
  • ???jsp.display-item.citation.isi??? 101
social impact